Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil chemotaxis refers to the directed movement of neutrophils toward sites of tissue damage or infection in response to external chemical stimuli. This process is a fundamental component of the innate immune response and enables rapid recruitment of neutrophils to inflamed tissues. It is orchestrated by chemoattractants such as fMLF peptides, C5a complement fragment, and IL‑8/CXCL8, acting on GPCRs like FPR family, CXCR1/CXCR2, and C5aR, triggering intracellular pathways involving Rho GTPases and PI(3,4,5)P3-mediated actin polymerization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil Chemotaxis.